Vectorite Biomedical Statistics

Total Valuation

TPEX:4170 has a market cap or net worth of TWD 601.86 million. The enterprise value is 431.82 million.

Market Cap	601.86M
Enterprise Value	431.82M

Important Dates

The next estimated earnings date is Monday, May 4, 2026.

Earnings Date	May 4, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4170 has 43.77 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	43.77M
Shares Outstanding	43.77M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	22.14%
Owned by Institutions (%)	n/a
Float	30.67M

Valuation Ratios

The trailing PE ratio is 6.28.

PE Ratio	6.28
Forward PE	n/a
PS Ratio	9.80
PB Ratio	1.24
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	4.49
EV / Sales	7.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.14

Financial Position

The company has a current ratio of 11.85, with a Debt / Equity ratio of 0.00.

Current Ratio	11.85
Quick Ratio	10.73
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-1,991.64

Financial Efficiency

Return on equity (ROE) is 21.98% and return on invested capital (ROIC) is -6.96%.

Return on Equity (ROE)	21.98%
Return on Assets (ROA)	-2.97%
Return on Invested Capital (ROIC)	-6.96%
Return on Capital Employed (ROCE)	-4.44%
Weighted Average Cost of Capital (WACC)	6.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.38% in the last 52 weeks. The beta is 0.44, so TPEX:4170's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+3.38%
50-Day Moving Average	13.61
200-Day Moving Average	13.64
Relative Strength Index (RSI)	48.28
Average Volume (20 Days)	72,864

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4170 had revenue of TWD 61.41 million and earned 96.17 million in profits. Earnings per share was 2.19.

Revenue	61.41M
Gross Profit	21.68M
Operating Income	-21.91M
Pretax Income	96.14M
Net Income	96.17M
EBITDA	-13.77M
EBIT	-21.91M
Earnings Per Share (EPS)	2.19

Full Income Statement

Balance Sheet

The company has 170.61 million in cash and 209,000 in debt, giving a net cash position of 170.40 million or 3.89 per share.

Cash & Cash Equivalents	170.61M
Total Debt	209,000
Net Cash	170.40M
Net Cash Per Share	3.89
Equity (Book Value)	485.08M
Book Value Per Share	11.10
Working Capital	175.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.79 million and capital expenditures -4.00 million, giving a free cash flow of -9.78 million.

Operating Cash Flow	-5.79M
Capital Expenditures	-4.00M
Depreciation & Amortization	8.14M
Net Borrowing	-144,000
Free Cash Flow	-9.78M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross margin is 35.31%, with operating and profit margins of -35.68% and 156.62%.

Gross Margin	35.31%
Operating Margin	-35.68%
Pretax Margin	156.57%
Profit Margin	156.62%
EBITDA Margin	-22.42%
EBIT Margin	-35.68%
FCF Margin	n/a

Dividends & Yields

TPEX:4170 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	15.98%
FCF Yield	-1.63%

Stock Splits

The last stock split was on August 27, 2015. It was a forward split with a ratio of 1.1005700953.

Last Split Date	Aug 27, 2015
Split Type	Forward
Split Ratio	1.1005700953

Scores

Altman Z-Score	n/a
Piotroski F-Score	1